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Use of a Retrospective Methodology
to Examine the Process of Care
Surrounding Serious Medical Events
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Abstract
Introduction: Comorbidities are increasingly common among people living with HIV (PLWH) as they age. There is no evidence
regarding models of care. We aimed to assess feasibility of a novel methodology to investigate care processes for serious medical
events in PLWH. Method: The method was based on the National Confidential Enquiry into Patient Outcome and Death
(NCEPOD). Data were extracted from medical records and questionnaires completed by general practitioners (GPs), HIV
physicians, and non-HIV specialist physicians. A panel reviewed anonymized cases and gave feedback on the review process.
Results: Eleven of 13 patients consented to the study. Questionnaires were completed by 64% of HIV physicians, 67% of non-HIV
specialist physicians, and 55% of GPs. The independent review panel (IRP) advised improvement in the methodology including data
presentation and timing. Conclusion: This method was acceptable to patients and secondary care physicians. Further work is
needed to the improve GP responses and facilitate IRP.
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Introduction
As a result of effective antiretroviral therapy (ART), HIV has
been transformed into a chronic disease with an excellent prog-
nosis. People living with HIV (PLWH) now have near-normal
life expectancy1 if ART is initiated promptly and a high level of
adherence to treatment is maintained.2 Life expectancy is
expected to improve even further as patients start therapy ear-
lier in the course of infection and with newer drugs.2
The number of older PLWH is rapidly increasing3; in 2017,
more than one-third of all PLWH in the United Kingdom were
aged older than 50 years, compared to just 13% in 2004.1 Effec-
tive treatment means PLWH now rarely experience opportunis-
tic infections.4 However, there are increasing numbers of people
with controlled HIV experiencing comorbid illnesses associated
with aging, but not traditionally associated with HIV,5,6 includ-
ing cardiovascular, renal, hepatic, bone, and metabolic disorders.
Both individual and multiple comorbidities appear to be more
common among peoplewithHIV than the general population.7-14
It is not yet known to what extent this is caused by HIV, ART, or
cofactors such as smoking, alcohol, or recreational drug use, which
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are all more common among PLWH.15,16 Living with multiple
comorbidities (multimorbidity) can have wide-reaching implica-
tions. In PLWH, multimorbidity has been associated with
reduced quality of life,17 difficulty maintaining employment,18
depression,19 increased use of medicines and polypharmacy,
health care, hospitalizations, and mortality.5,20-22 The preven-
tion, prompt detection, and effective management of serious
medical events and related comorbidities is now a priority.
The current cohort of older PLWHwith an array of comorbid-
ities is unprecedented, and HIV services in the United Kingdom
were not developedwith this population inmind.Anewapproach
to care may be required to meet their needs. Over recent years,
several newapproaches havebeenproposed todetect andmanage
comorbidities. These include a wider involvement of primary
care in the management of HIV similar to the integrated model
that applies to other chronic conditions in the National Health
Service (NHS),17 combined clinics with 1 or more specialists
working alongside the HIV clinician,18 HIV specialists adopting
a special interest (eg, liver disease),19 and dedicated clinics for
enhanced screening for comorbidities.20 Contrary to the recom-
mendations of the Department of Health,21 these new approaches
to care have been developed in the absence of an evidence base
and without consideration of patients’ preferences.
In order to develop novel and appropriate approaches for
care of HIV-positive patients with comorbidities, it is necessary
to understand the way care is currently delivered and, more
importantly, which processes are amenable to improvement.
We have developed a novel methodology, derived from that
used by the National Confidential Enquiry into Patient Out-
come and Death (NCEPOD), to examine the process of care
of HIV-positive patients who had experienced a preventable
serious medical event.
Aim
The aim of this pilot study was to examine the feasibility of
using this retrospective methodology. If feasible, this metho-
dology can be used to (1) examine the process of care of HIV-
positive patients who have experienced a serious medical event
(myocardial infarction [MI], stroke, drug–drug interaction
[DDI], or progression to chronic kidney disease [CKD] stage
3); (2) identify aspects of care that could have been provided
differently to improve care; and (3) use these insights to make
recommendations for a future model of care.
Method
Themethodology used in this study was based on that used in the
United Kingdom by the NCEPOD to identify remediable factors
in the process of care of patients who experienced a specific
outcome or event NCEPOD methods have been used to investi-
gate a range of clinical events including deaths due to chemother-
apy, pain in sickle cell disease, and acute kidney injury, among
others.23 To our knowledge, NCEPOD methods have not been
previously used to investigate events specifically in PLWH. The
stages typically followed in an NCEPOD study can be found in
Figure 1; they involve review of a sample of cases by a
– An expert panel is convened for each event, and identifies
areas of surgical and medical care relating to the outcome or
event to be explored in more detail
– Patients meeting the criteria for the event are identified in
hospitals across the UK from which random samples of
patients are selected.
– A clinical questionnaire, designed specifically for the study to
collect data on the key stages of patient care relating to the
event, is sent to the secondary care consultant physician or
surgeon who was providing care for the patient at the time of
the event.
– An organisational questionnaire, designed specifically for the
study to collect data on organisational facilities and processes
relating to the event, such as staffing and facilities, is sent to
each hospital.
– Copies of case notes (typically for the period of a hospital
admission) are requested.
– A multidisciplinary group of advisors from relevant specialties
is recruited to peer-review a sample of anonymised case notes
and questionnaires. Each case is reviewed by at least one
advisor using a semi-structured assessment form. The advisor
enters their ratings into a database containing tick boxes
(quantitative data) and free text boxes (qualitative data). The
advisor indicates where there is insufficient information in the
case notes to make a decision.
– The NCEPOD chair allows a period of discussion where each
advisor summarises their cases and asks the other panel
members for opinions or raises aspects of care for
discussion.
– A grading system is used to rate the overall care for each
patient.
Figure 1. The stages typically followed in a National Confidential
Enquiry into Patient Outcome and Death (NCEPOD) study.
What Do We Already Know About This Topic?
HIV services in the United Kingdom were not developed
for an aging population of people living with HIV
(PLWH), there is an evidence deficit regarding the best
model of care for older PLWH with multimorbidity.
HowDoes Your ResearchContribute to the Field?
We developed a novel methodology based on NCEPOD to
review the current model of care for older PLWH who
experience a serious medical event.
What Are Your Research’s Implications Toward
Theory, Practice, or Policy?
The methodology was acceptable to patients and second-
ary care physicians. However, further research is needed
to modify the methodology in order to promote engage-
ment and to identify areas of health care for PLWH who
are amenable to change, ensuring that further service
design is informed by evidence
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multidisciplinary panel, with a semistructured assessment and a
focus on qualitative outcomes.23 We adapted this methodology
and applied it to examine the process of care of PLWH who had
experienced a serious medical event using a 3-stage process:
1. Questionnaire completion by clinicians involved in
the case
2. Case note review
3. Review by an independent review panel (IRP).
This study was undertaken at Brighton and Sussex Univer-
sity Hospital from January to August 2015.
Definition of the Serious Medical Events
The 4 serious medical events were selected on the basis that
they were theoretically preventable, and therefore there may
have been a missed opportunity in the care of the patient. Those
selected were MI, stroke, a serious DDI (prescription of inter-
acting drugs which should not be coprescribed) according to
www.hiv-druginteractions.org,24 and progression to CKD stage
3 (estimated glomerular filtration rate of 30 to 59 mL/min/1.73
m2 for >90 days).25
Participants
People living with HIV aged 16 years who had experienced
MI, stroke, DDI, or progression to CKD stage 3 within the past
3 years were identified by the clinical team at Brighton and
Sussex University Hospital (Figure 2). Eligible patients were
first approached by their usual clinician, and if interested, a
researcher contacted them to provide a patient information
sheet and request consent.
Sample Size
To explore the feasibility of the method, we aimed to recruit a
total of 12 patients, 3 patients with 1 of the 4 conditions. This
was in accordance with NCEPOD methods that use a sample of
cases and do not attempt to survey all cases with the condition
or event of interest. The sample size was thought to be prag-
matic and sufficient to assess feasibility, in keeping with other
feasibility studies.25-28
Questionnaires and Case Note Review
Draft questionnaires were developed based on NCEPOD ques-
tionnaires with input from patients and clinicians. These were
then reviewed and pretested by an HIV physician, a non-HIV
specialist physician, and 2 general practitioners (GPs) who sug-
gested changes including reducing the length of the questionnaire
and simplifying wording. The questionnaires had 2 sections. Sec-
tion 1 explored the clinical details before, during, and after the
event, as well as communication between teams, and section 2
explored experience of completing section 1 including process,
time, and suitability of questions. One questionnaire per patient
was sent to the HIV physician, non-HIV specialist physician, and
GP caring for the patient. If there was no reply after 2 weeks, the
clinician received a follow-up phone call or an e-mail.
Hospital case notes were reviewed and data recorded on a
structured data collection form by research clinicians with
experience in infectious diseases. The information extracted
via case note review allowed the questionnaires for secondary
care clinicians to be shorter than those originally developed, in
order to maximize response rate. Case notes were reviewed
from 18 months prior the event to 12 months post event. Data
collected included patient demographics, clinical data (inves-
tigations, diagnoses, and management), and communication
between clinical teams. In addition, hospital notes related to
the event were copied and anonymized.
Independent Review Panel
Panel members were asked to review each of the cases using a
structured assessment form. The IRP was comprised of an HIV
consultant, an HIV specialist nurse, an HIV pharmacist, 2 GPs,
and 2 non-HIV specialist physicians (a geriatrician and a
nephrologist). Data bundles were collated for each case and
provided to the IRP. These included the questionnaires, case
note data collection form, and anonymized medical records.
The IRP’s feedback was sought on 2 elements: the review
process and the cases. Regarding the review process, areas
explored included adequacy of information, missing data,
unnecessary information, and what could be done differently
to improve the review process. Regarding the cases, the process
of care surrounding the event was explored; areas included
primary and secondary prevention, communication between
teams, ownership of care, and an overall rating of care. After
completion of the assessment form by the IRP, there was a case
discussion in order to capture additional views on the review
process. The discussions were recorded and analyzed.
Outcome Measures
The factors used to assess feasibility were (1) the proportion of
eligible patients who gave consent to participate in the study
and barriers to consent; (2) the proportion of clinicians con-
tacted who returned completed questionnaires; (3) barriers to
questionnaire completion; (4) the quality of data collected by
the questionnaires (proportion of items completed and feed-
back on the process); and (5) feedback from the IRP on the
quality of information received and the review process. The
secondary outcome was the IRP’s rating of the overall care
received by patients who had experienced each event.
Data Analysis
Data from clinician questionnaires and structured assessment
forms completed by the IRP were entered into a Microsoft
Excel database. Descriptive data were summarized and pre-
sented in tables. Data from free-text boxes and panel discus-
sions were reviewed, and content analysis was undertaken by a
researcher (E.Y.).
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Procedures in Place in Case Harmful Practice Was
Identified
In advance of commencing the case reviews, procedures that
were established in case harmful practice was identified during
case review, although no such practice was identified in our
study. If harmful practice had been identified, the chief
investigator (CI—J.W.) would have accessed a password-
protected database and relinked the participant’s unique study
code to their name and hospital number and contacted the
relevant clinical team. If there had been significant concern
that the patient was at ongoing risk, the CI would have con-
tacted the trust medical director (for secondary care) or NHS
Eligible paents contacted by a member of the clinical team
Request hospital records
Data collecon
Researcher completes data collecon form using hospital and HIV records
Clinical quesonnaire sent to HIV physician, specialist (were appropriate) and GP involved in the paent’s
care leading up to/during/post event
Reminders
Reminders were sent to any clinician aer two weeks if quesonnaires had not been returned. This was
repeated up to three mes. In order to facilitate quesonnaire compleon, HIV notes and/or hospital notes
were sent to HIV physicians and specialist physicians were possible
Review by independent panel
Meeng of the independent review panel where anonymised case notes and quesonnaires were reviewed
using a semi-structured review form. Aer each event a group discussion of each caseand any
recommendaons to improve process discussed.
Idenﬁcaon of eligible paents
Searching clinical databases for event codes and test results (MI, Stroke and CKD), and HIV
consultant/pharmacist’s recollecon (DDI)
Interested paents contacted by a member of the research team
Paent informaon sheet given and wrien informed consent given from paents wanng to take part in 
the study
Anonymise data
Anonymising paent and clinician idenfying informaon by removal or blacking out.
Figure 2. Flow diagram showing the stages of the research.
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England (for primary care). If we had identified an event where
the duty of candor applied29,30 and moderate harm, severe
harm, or death occurred, then the CI would have informed the
relevant clinical team(s) and deferred the duty of candor to the
clinical team(s).
Ethical Approval and Informed Consent
This study was approved by the Research Ethics Service Com-
mittee West Midlands—Coventry andWarwickshire; reference
number 15/WM/0039. All patient participants provided written
informed consent prior to enrolment in the study. Written infor-
mation regarding the study was provided to clinicians complet-
ing the questionnaires; written consent from the clinicians was
not required.
Results
The primary outcome measures of this study relate to the fea-
sibility of the method, and the secondary outcomes relate to the
IRP review of each case.
Feasibility Outcomes
Patient recruitment. Patient recruitment is summarized in Fig-
ure 3. Of 18 patients identified as eligible for the study, 11
(61.1%) patients were recruited. Four patients were not
contacted because their HIV physician felt that it would not
be appropriate, and 2 patients were contacted but declined to
take part. Of the 2 patients who declined, 1 declined due to ill
health and 1 queried their eligibility. One patient did not pro-
vide written consent until after the review panel meeting had
taken place; therefore, no questionnaires or data collections
were completed.
Questionnaire responses. Overall, 31 questionnaires were sent
out relating to the 11 patient cases: 11 to HIV physicians, 11
to GPs, and 9 to non-HIV specialist physicians. In 2 cases, the
patient had not seen a non-HIV specialist physician during the
study period; therefore, for these cases, questionnaires were
only sent to the HIV physician and GP. In total, 17 (54.8%)
of 31 questionnaires were returned and completed, and this
differed according to the role of the clinician. A similar pro-
portion of questionnaires were returned completed by HIV
physicians and non-HIV specialist physicians, 63.6% and
66.7%, respectively. One questionnaire could not be com-
pleted, as the only HIV physician involved in the patient’s care
died during the study period. One non-HIV specialist physician
reported they did not complete the questionnaire due to being
unable to trace the medical notes. The response rate for GPs
was lower; 4 (36.4%) of 11 questionnaires were returned and
complete. One GP reported the questionnaire was too long, and
2 GPs declined as there was no financial reimbursement for
Patients identified as eligible
(n= 18)
Not recruited (n= 6)
♦ Patient not approached at request of
HIV clinician (n= 4)
♦ Patient did not agree that they were
eligible (n= 1)
♦ Patient declined to discuss study due
to illness (n= 1)
Patients included in the analysis (n= 11)
Patients for whom data was collected and
considered at the review panel (n= 11)
Analysis
Patients enrolled (n= 12)
Enrollment
Patient returned completed consent form
after the review panel (n= 1)
Data collecon
and Review panel
Figure 3. Patient recruitment.
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their time. The time taken to complete questionnaires varied
from a median of 13 minutes for HIV physicians to 35 minutes
for GPs (Table 1). The majority of clinicians answered all
questions (Table 1).
Questionnaire feedback. Clinicians indicated that the following
types of questions were difficult to answer: questions about how
care could be improved, requests to identify which clinician was
primarily responsible for a patient’s care, and those asking about
communication between health-care teams. A non-HIV special-
ist physician indicated it was difficult to answer questions about
time periods when they were not involved in the patients care.
Additional questions suggested by clinicians to be included in
questionnaires included a question to identify possible circum-
stances in which communication between clinicians was diffi-
cult (eg, to protect patient confidentiality) and a question about
follow-up after the identification of a DDI. Two suggestions
were made: shortening the GP questionnaire and presenting the
questions in a chronological order.
Findings from the independent review panel. Panel members felt
that the 20 minutes provided for review of each case was insuf-
ficient. Although some felt reducing the amount of cases per
panel and allowing more time per case would help, there was
agreement that presenting the data differently would also facil-
itate the review. It was suggested that questionnaires should be
sent to all clinicians the patient had seen within the study period,
including those from other NHS trusts. Information from the GP
was considered to be essential. Copied hospital and GP notes,
discharge summaries, and letters were useful.
Panel members suggested making clinical guidelines readily
available at the IRP would be helpful. In addition, further
questions about prevention was suggested to improve the utility
of the questionnaire to the panel. While anonymized copies of
hospital and GP records, including discharge summaries and
clinical letters, were provided to the IRP, panel members
wished to see additional information including laboratory and
radiology reports, all patient communication (eg, follow-up
communication if a patient did not attend an appointment), and
information on psychosocial issues. Panel members also sug-
gested a case summary, including timeline of events, would
help facilitate the case review.
Ratings of the Quality of Care
Individually, IRP participants expressed a lack of confidence in
their ratings of overall care due to insufficient time to conduct
each review and in light of missing data, particularly from GPs.
Participants indicated that there were insufficient data avail-
able to rate care in 30% of occasions (26 of 88 possible ratings).
Of those rated, panel members indicated that there was room
for improvement in care for most cases, 40 (65%) of 62,
although good practice was seen (22 of 62, 35% cases). No
panel members indicated that care was less than satisfactory
(Table 2), and no harmful practice was identified.
Discussion
Our findings demonstrate that this methodology met some,
but not all, of the predefined outcomes for feasibility.
Domains that were considered feasible include patient partic-
ipation, questionnaire completion by secondary care physi-
cians, and quality of completed questionnaire data. Clinical
questionnaires were returned by approximately two-thirds of
secondary care physicians (HIV and non-HIV specialists);
Table 2. Rating of Overall Care by Independent Review Panel Members.
Number of Reviews Overall Care Rating
Type of Event (Number
of Cases Reviewed)
Number of
Reviewers
Number of Cases  the
Number of Reviewers
Good
Practice, n (%)
Room for
Improvement, n (%)
Less Than
Satisfactory, n (%)
Insufficient Data to
Assess Quality, n (%)
CKD (2) 8 16 2 (29) 5 (71) 0 9 (56)
DDI (3) 8 24 1 (5) 19 (95) 0 4 (17)
MI (3) 8 24 9 (53) 8 (47) 0 7 (29)
Stroke (3) 8 24 10 (56) 8 (44) 0 6 (25)
Total (11) 8 88 22 (35) 40 (65) 0 (0) 26 (30)
Abbreviations: CKD, chronic kidney disease progression to stage 3; DDI, drug–drug interaction; MI, myocardial infarction.
Table 1. Completion of the Clinician Questionnaires.
Questionnaires
Sent, n
Questionnaires
Returned, n (%)
Time Taken, minutes,
Median (Range)
Questionnaire Items
Completed, %, Median (Range)
Case Notes
Returned, n (%)
HIV physician 11 7 (63.6) 13 (5-25) 100 (91-100) 7 (63.6)
Non-HIV physician 9 6 (66.7) 7 (5-10) 100 (82-100) 1 (11.1)
GP 11 4 (36.3) 35 (25-40) 100 (22-100) 4 (36.3)
Abbreviation: GP, general practitioners.
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only a third of GPs returned completed questionnaires. This
will require substantial modification to the method. Similarly,
further adaptation is required to the questionnaire process and
data provision to the IRP.
The questionnaire return rate for this pilot is lower than 3
most recent return rates reported by NCEPOD (range: 80%-
86%).30-33 Response of NCEPOD questionnaires may be
enhanced by the NCEPOD policy of identifying a named con-
tact (the NCEPOD local reporter) at each hospital who acts as a
link between NCEPOD and hospital staff in order to facilitate
data collection and return. General practitioners were required
to provide greater amounts of data than their secondary care
colleagues, as the research team was unable to assist them in
the extraction of information from the primary care electronic
health records, whereas, for secondary care clinicians, the
research team had access to hospital records and so the ques-
tionnaire was shorter.
General practitioners reported that they had insufficient time
for research tasks, and some requested financial compensation
for their time. In the future, we need to consider financial
incentives for completed questionnaires. In addition, if the
research team were able to obtain access to the primary care
databases to extract data as they did for hospital records, the
length of GP questionnaires could be reduced. Although
patients, hospital physicians, pharmacists, and GPs contributed
to the study design, our experience indicates that further patient
involvement and consultation with GPs will be required to
refine the methodology to enhance GP involvement and opti-
mize return rates.
The creation of the data bundles, including anonymized
medical records, was valued by IRP members and however was
extremely time intense for the research team. The quality of
data returned was high, with a median of 100% questionnaire
items completed. Feedback from clinicians indicated that the
areas that they had most difficulty answering were questions
regarding the communication between various teams and deter-
mining which team had responsibility for managing the patient.
These are areas of particular interest in the prevention and
management of comorbidity, since it has been recognized pre-
viously that problems in communication between teams can be
problematic as has previously been reported in studies of
patients with multimorbidity.34-36 Additional questionnaire
content may be generated by literature review and qualitative
research. By investigating 4 different serious medical events,
the lessons learnt are more general, such as communication, as
the causative factors for each medical event may differ. More
specific lessons could be learnt by investigating 1 type of event
alone, such as DDI.
Feedback from the IRP highlighted several areas in which
our methodology needs to be improved, including greater time
allocated for the review, the collection and presentation of
additional information, the inclusion of a patient summary, and
a timeline of events. Missing data were flagged as a particular
problem when attempting to assess the quality of care. These
findings emphasize the need for significant modifications to the
methodology in order to optimize completion and return rates,
and in order to assess the quality of care, before embarking on a
larger study.
Conclusions
In our small sample, we found that the method was acceptable
to patients, and there were satisfactory return rates from sec-
ondary care physicians. Further work is needed to refine the
methodology in order to increase data returns from GPs and to
facilitate the independent panel review.
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